skip to main content

We know more about cancer today thanks to the biological, molecular and genomic discoveries, new technologies, tests and treatments made possible with research funding from The Terry Fox Foundation and through the translational work undertaken by TFRI. As a result, we have better ways to detect, diagnose and treat cancer today. This is helping cancer patients to live, to live longer and with a better quality of life.

There are three areas of Terry Fox research funding: the discovery and development of new knowledge and technologies; translating discoveries from the laboratory to the clinic for the benefit of cancer patients; training and supporting the future leaders of cancer research.

 

  • Cancer Type
  • Cancer Topic
  • Funding Program
  • Location
  • Partner
  • Researcher
  • Blood Cancers
  • Brain Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Head & Neck Cancers
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric & Young Adult Cancers
  • Prostate Cancer
  • Rare Cancers
  • Sarcoma
  • Biobanking
  • Cancer Biology
  • Cancer Drugs
  • Cancer Metastasis
  • Cancer Prevention
  • Chemotherapy & Radiation
  • Early Detection & Diagnosis
  • Immunotherapy
  • New Technologies
  • Precision Medicine
  • Terry Fox New Investigator Award
  • Terry Fox New Frontiers Program Project Grants
  • Terry Fox Translational Research Program
  • Marathon of Hope Cancer Centres Network Pilots
  • Terry Fox Cancer Research Training Program
  • Other Programs
  • Canada Wide
  • Ontario
  • British Columbia
  • Alberta
  • Québec
  • Manitoba
  • New Brunswick
  • Newfoundland and Labrador
  • Nova Scotia
  • Saskatchewan
  • Prince Edward Island
  • Alberta Cancer Foundation
  • Alberta Health Services
  • Alberta Innovates - Health Solutions
  • Atlantic Cancer Research Institute
  • BC Cancer
  • BC Cancer Foundation
  • BC Children's Hospital
  • Beatrice Hunter Cancer Research Institute
  • BioCanRX
  • Brock University
  • Canada's Michael Smith Genome Sciences Centre
  • Canadian Institutes of Health Research
  • Canadian Partnership Against Cancer
  • CancerCare Manitoba
  • Centre de recherche de Centre hospitalier de L’Université de Montréal
  • Centre de Recherche Hôpital Maisonneuve-Rosemont
  • Centre for Drug Research and Development
  • Centre Hospitalier de L’Université de Montréal
  • Children's Hospital of Eastern Ontario Research Institute
  • CHU - Quebec
  • CHU - Sainte-Justine
  • Cross Cancer Institute
  • CSSS Champlain—Charles-Le Moyne
  • Dalhousie University
  • Dr. Georges-L.-Dumont University Hospital Centre
  • Genome BC
  • Genome Canada
  • Hôpital du Sacré-Coeur de Montréal
  • Hôpital Maisonneuve-Rosemont
  • Hôtel-Dieu de Québec
  • Institut Universitaire de Cardiologie et de Pneumologie de Québec
  • IWK Health Centre
  • Jewish General Hospital
  • Juravinski Cancer Centre
  • London Health Sciences Centre
  • Lunenfeld-Tanenbaum Research Institute
  • McGill Cancer Centre
  • McGill University
  • McGill University Health Centre
  • McMaster University
  • Memorial University of Newfoundland
  • Montreal Children's Hospital
  • Mount Sinai Hospital
  • National Science Council (NSC)
  • New Brunswick Cancer Network
  • New Brunswick Health Research Foundation
  • Ontario Institute for Cancer Research
  • Ottawa Hospital Research Institute
  • Princess Margaret Cancer Centre
  • Quebec Breast Cancer Foundation
  • Queen's University
  • Research Manitoba
  • Ryerson University
  • Saskatchewan Cancer Agency
  • Saskatchewan Health Research Foundation
  • Simon Fraser University
  • Sinai Health System
  • St. Mary’s Hospital Center
  • St. Paul's Hospital
  • Sunnybrook Health Sciences Centre
  • Team Finn Foundation
  • The C17 Council
  • The Hospital for Sick Children
  • The Terry Fox Foundation
  • Tom Baker Cancer Centre
  • Université de Montreal
  • Université de Sherbrooke
  • Université Laval
  • Université Sherbrooke
  • University Health Network
  • University of Alberta
  • University of British Columbia
  • University of Calgary
  • University of Guelph
  • University of Manitoba
  • University of New Brunswick
  • University of Ottawa
  • University of Prince Edward Island
  • University of Saskatchewan
  • University of Toronto
  • Vancouver Coastal Health Research Institute
  • Vancouver General Hospital
  • Vancouver Prostate Centre
  • Aaron Hansen
  • Adam Shlien
  • Alain Piché
  • Alan So
  • Alejandro Berlin
  • Alex Kiss
  • Alexandre Bouchard-Côté
  • Aly Karsan
  • Amina Zoubeidi
  • Amit Oza
  • Andrea Doria
  • Andrea McCart
  • Andrew Weng
  • Anna Goldenberg
  • Anna Tinker
  • Anne-Claude Gingras
  • Anthony (Tony) Reiman
  • Anthony Fyles
  • Artem Cherkasov
  • Barbara Vanderhyden
  • Bartha Knoppers
  • Benjamin Haibe-Kains
  • Benoit Samson
  • Bernard Czjazowski
  • Bernard Lesperance
  • Brad Nelson
  • Bradly Wouters
  • Brian Lichty
  • Brian Wilson
  • Britt Andersen
  • Byram Bridle
  • Calum MacAulay
  • Carl Brown
  • Christian Steidl
  • Christine Demore
  • Christopher Ong
  • Christopher Rudd
  • Claude Perreault
  • Colin Collins
  • Colleen Bailey
  • Connie Eaves
  • Daniel Renouf
  • Daniel Sinnett
  • Darrel Drachenberg
  • Darrell Fox
  • David Cescon
  • David Goertz
  • David Hedley
  • David Huntsman
  • David Jaffray
  • David Kaplan
  • David Malkin
  • David Schaeffer
  • David Scott
  • David Stojdl
  • Dimcho Bachvarov
  • Donna Reece
  • Donna Senger
  • Dr. Anne-Marie Mes-Masson
  • Dr. Chris Paige
  • Dr. David Eisenstat
  • Dr. Marco Marra
  • Dr. Marla Shapiro
  • Dr. Michael Johnston
  • Dr. Robert Rottapel
  • Dr. Spencer Gibson
  • Dr. Stephen Robbins
  • Dr. Victor Ling
  • Eldad Zacksenhaus
  • Emma Guns
  • Eve St. Hilaire
  • Francis Rodier
  • François Benard
  • François Mercier
  • Frank Sicheri
  • Fred Saad
  • Frédérick Mallette
  • Gang Zheng
  • Gary Bader
  • George Zogopoulos
  • Gerald Batist
  • Gerry Johnston
  • Gregg Morin
  • Gregory Cairncross
  • Gregory Czarnota
  • Gregory Stanisz
  • Guillaume Bourque
  • Guy Ungerechts
  • Haili Wang
  • Hal Berman
  • Helen Steed
  • Housheng Hansen He
  • Ian Watson
  • Isabelle Bairati
  • James Woodgett
  • Janessa Laskin
  • Janet Dancey
  • Jason Berman
  • Jason Moffat
  • Jeanette Boudreau
  • Jean-Sebastien Delisle
  • Jean-Simon Diallo
  • Jeff Wrana
  • Jennifer Chan
  • Jeremy Squire
  • John Bell
  • John Dick
  • John Kelly
  • John Mayo
  • John Stagg
  • John Yee
  • Jonathan Bramson
  • Jonathan Irish
  • Jonathan Sussman
  • Josée Hébert
  • Julie St-Pierre
  • Karen Mossman
  • Kathy Brodeur-Robb
  • Kathy Han
  • Kelly Curwin
  • Kim Chi
  • Kullervo Hynynen
  • Lambert Busque
  • Laurence Klotz
  • Lesley Seymour
  • Liliana Attisano
  • Lillian Siu
  • Linda Penn
  • Livia Garzia
  • Lorien Lantomasi
  • Louis Lacombe
  • Lucas Sideris
  • Mads Daugaard
  • Marcus Butler
  • Margaret Fitch
  • Marianne Koritzinsky
  • Marlene Manson
  • Martin Gleave
  • Martin Hirst
  • Martin Koebel
  • Martin Tammemagi
  • Mathieu Latour
  • Mathieu Lupien
  • Matthew Cheung
  • Meaghan O'Reilly
  • Meredith Giuliani
  • Michael Brauer
  • Michael Cox
  • Michael D. Taylor
  • Michael Kolios
  • Michael Milosevic
  • Michael Moran
  • Ming-Sound Tsao
  • Morag Park
  • Nada Jabado
  • Nahum Sonenberg
  • Naoto Hirano
  • Natasha Leighl
  • Neesha Dhani
  • Neil Fleshner
  • Nizar Bahlis
  • Norman Iscove
  • Oliver Bathe
  • Pamela Ohashi
  • Patricia Shaw
  • Patricia Tang
  • Patrick Parfrey
  • Paul Karanicolas
  • Peter Dirks
  • Peter Mothe
  • Peter Siegel
  • Peter Stirling
  • Peter Watson
  • Pierre Karakiewicz
  • Poul Sorensen
  • Ralph Buttyan
  • Ralph DaCosta
  • Rayjean Hung
  • Rebecca Auer
  • Réjean Lapointe
  • Richard Dalfen
  • Richard Hill
  • Rima Al-Awar
  • Rob Holt
  • Robert Kridel
  • Robert Rottapel
  • Robert Weersink
  • Rod Rassekh
  • Rodger Tiedemann
  • Ronald Burkes
  • Russell Jones
  • Russell Watkins
  • Ryan Morin
  • Sachedev Sidhu
  • Sachin Katyal
  • Samuel Aparicio
  • Samuel Weiss
  • Sarit Assouline
  • Sean Egan
  • Shabbir Alibhai
  • Shane Duan
  • Sharlene Gill
  • Sheila Singh
  • Simon Sutcliffe
  • Simone Chevalier
  • Sohrab Shah
  • Sonya Cressman
  • Stéphanie Lheureux
  • Stephen Herst
  • Stephen Lam
  • Stephen Yip
  • Steven Gallinger
  • Steven Jones
  • Stuart Foster
  • Suzanne Trudel
  • T. Michael Underhill
  • Tomas Hudlicky
  • Tommy Alain
  • Torsten Nielsen
  • Trevor Dummer
  • Trevor Pugh
  • Trevor Shepherd
  • Ur Metser
  • Vincent Giguère
  • Walter Gotlieb
  • Warren Mason
  • William Foulkes
  • William Muller
  • Wilson Miller
  • Yonghong Wan
  • Yoo-Joung Ko
  • Yuzhuo Wang
  • Colorectal Cancer

    Pan-Canadian colorectal cancer consortium (C4)

    Colorectal cancer is the second leading cause of cancer death in Canada, with about one in every 14 people likely to develop the disease. TFRI’s Pan-Canadian Colorectal Cancer Consortium (C4) is...

    Read More
  • Prostate Cancer

    A pan-Canadian initiative for the development of a biomarker-driven approach to the management of prostate cancer

    A collection of more than 2,000 tumour samples. Over a dozen Canadian researchers. Four provinces. These are just some of the numbers behind TFRI’s Canadian Prostate Cancer Biomarker Network (CP...

    Read More
  • Brain Cancer

    Modeling and therapeutic targeting of the clinical and genetic diversity in glioblastoma multiforme

    Glioblastoma is a deadly brain cancer that currently has no cure, and has lagged behind major treatment advances other cancers have benefited from. But there’s hope: an Alberta-based, TFRI-funde...

    Read More
  • Ovarian Cancer

    Canadian ovarian cancer research consortium

    Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. More than one in four women do not respond to standard first-line chemotherapy treatment — an alarming nu...

    Read More
  • Multiple Cancers

    Bubble-mediated therapy for metastatic disease in the spinal cord

    A Toronto-based researcher is hoping to turn the tide on a deadly late-stage cancer complication thanks to a recently won TFRI New Investigator award. Dr. Meaghan O’Reilly, an ultrasound scient...

    Read More
  • Multiple Cancers

    Deciphering metastasis maintenance events in adolescents and young adults' sarcoma

    As Terry Fox approached the city of Thunder Bay in Ontario on Sept. 1, 1980, a strange pain took hold of his chest. The 22-year-old had been coughing for days, but it wasn’t until the pain made ...

    Read More
  • Ovarian Cancer

    Natural killer cells: new weapons in the iTNT cache for ovarian cancer immunotherapy

    How can immunotherapy for one of the deadliest types of ovarian cancer be made more efficient and effective for patients? Dr. Jeanette Boudreau, a newly funded Terry Fox New Investigator awardee at D...

    Read More
  • Multiple Cancers

    Montreal Cancer Consortium Pilot for the Marathon of Hope Cancer Centres

    Leading researchers, cancer centres and hospitals in Montreal have partnered with The Terry Fox Research Institute to generate new advances in personalized and precision medicine and improve treatment...

    Read More
  • Multiple Cancers

    Ultrasound and MRI for cancer therapy

    A research team based out of Toronto’s Sunnybrook Health Sciences Centre is on track to begin trials on the use of ultrasound-stimulated microbubbles in breast cancer patients thanks to new...

    Read More
  • Rare Cancers

    New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

    A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...

    Read More
  • Pediatric & Young Adult Cancers

    Early detection and prevention of cancer in Li-Fraumeni Syndrome

    A team of Toronto- and Halifax-based scientists has received renewed funding from the Terry Fox Research Institute to continue its groundbreaking research into Li-Fraumeni Syndrome (LFS)—a rare ...

    Read More
  • Brain Cancer

    Targeting resistant glioblastoma multiforme (rGBM) through suppression of overactive DNA repair activity

    DNA repair biologist Dr. Sachin Katyal has been awarded Manitoba’s first TFRI New Investigator Award for his quick-to-clinic personalized medicine approach to better treat patients with the incu...

    Read More
  • Blood Cancers

    Dissecting biological heterogeneity in follicular lymphoma into clinically relevant molecular subtypes

    One of the most frustrating parts of Dr. Robert Kridel’s work is not being able to tell patients diagnosed with follicular lymphoma if they will respond well to treatment or not – a realit...

    Read More
  • Pancreatic Cancer

    Enhanced pancreatic cancer profiling for individualized care (EPPIC)

    Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease. “For many years it’s been hopeless from a pa...

    Read More
  • All Cancers

    Strategic training in transdisciplinary radiation science for the 21st century

    Today, radiation is used to diagnose and treat many medical conditions, including most cancers. This radiation, which can take several forms, plays a role in everything from imaging to therapy, and is...

    Read More
  • All Cancers

    Cancer Research Training Program in Atlantic Canada

    Providing high-quality training and opportunities to promising new scientists across Canada is critical to ensure continued leadership and advancement in cancer research. It is also necessary to make ...

    Read More
  • Multiple Cancers

    Porphysome nanoparticle-enabled image-guided cancer interventions

    Renewal funding from the Terry Fox Research Institute will enable a Toronto-based research group to change the cancer imaging landscape by preventing overtreatment and, consequently, decreasing the ne...

    Read More
  • Blood Cancers

    Exploiting pathogenic mechanisms in acute leukemia for clinical translation

    A longstanding Terry Fox-funded project on hard-to-treat leukemias has been renewed, and the new injection of funds --$7.4 million over five years -- will help to further understand the differences be...

    Read More
  • All Cancers

    Canadian Oncolytic Virus Consortium (COVCo)

    In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...

    Read More
  • Pediatric & Young Adult Cancers

    Single cell dissection and non-invasive monitoring of childhood cancer and immune systems during treatment

    How do different pediatric tumours respond to immunotherapy? That’s the primary question a newly funded TFRI investigator seeks to answer. Using immunotherapy to destroy cancer cells is an exci...

    Read More
  • Multiple Cancers

    Functionalizing SWI/SNF chromatin remodeller mutations in rare and common tumours

    Cancer is a disease driven by mutations in normal DNA, and a newly funded TFRI researcher is working to better understand a type of gene mutation that affects around 40,000 Canadians with both rare an...

    Read More
  • Multiple Cancers

    Deciphering the oncogenic properties of cancer-associated IDH1/2 mutations

    TFRI New Investigator Dr. Frédérick Mallette is breaking new ground in his efforts to characterize metabolic defects associated with brain cancer and leukemia, paving the way for new app...

    Read More
  • Prostate Cancer

    Understanding the function of circular RNA in tumour hypoxia

    A newly funded TFRI researcher at Toronto’s Princess Margaret Cancer Centre is building on existing hypoxia research to discover new ways to kill some of the most aggressive and treatment-resist...

    Read More
  • Lung Cancer

    Early detection of lung cancer

    Why are non-smokers with little exposure to second-hand smoke diagnosed with the disease while others are not? Why do some heavy smokers never develop lung cancer, while other lighter smokers do? Thes...

    Read More
  • Blood Cancers

    Multiple myeloma molecular monitoring (M4) cohort study

    When Dr. Tony Reiman is looking for inspiration for his TFRI-funded project on multiple myeloma, he thinks of patients he’s lost to the deadly, incurable cancer that affect the blood and bone ma...

    Read More
  • All Cancers

    Canadian Tissue Repository Network (CTRNet)

    To do their jobs, cancer researchers need to be able to access high-quality tumour samples. These samples allow them to test new drugs, observe similarities and differences between tumours and learn m...

    Read More
  • Brain Cancer

    Targeting clonal heterogeneity in treatment-refractory glioblastoma with novel and empiric immunotherapies

    A newly funded TFRI “dream team” plans to tackle the most lethal and aggressive brain tumour that occurs in adults by focusing not on the original tumour, but on the relapsed cancer. &ldqu...

    Read More
  • Breast Cancer

    New era of precision medicine in triple-negative breast cancer

    Triple-negative breast cancer (TNBC) persists as a deadly form of breast cancer today that lacks effective therapies. Now, a newly formed and funded Terry Fox Research Institute team hopes to employ a...

    Read More
  • Colorectal Cancer

    Targeting the hippo signaling network in cancer

    In order for cancer to grow inside our bodies, it must overcome a series of control mechanisms that are important for tissue growth. One mechanism which is responsible for body organ size is aptly cal...

    Read More
  • Prostate Cancer

    Targeting the adaptive molecular landscape in castrate-resistant prostate cancer

    TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry ...

    Read More
  • Blood Cancers

    Overcoming treatment failure in lymphoid cancers

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their...

    Read More
  • Ovarian Cancer

    Immunotherapy network (iTNT): targeting ovarian cancer

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the four...

    Read More
  • Multiple Cancers

    BC Cancer-Princess Margaret Pilot for the Marathon of Hope Cancer Centres

    In February of 2017, the Terry Fox Research Institute and two leading cancer centres in Canada – the Princess Margaret Cancer Centre in Toronto and BC Cancer in Vancouver –&...

    Read More
  • Pediatric & Young Adult Cancers

    Precision oncology for young people (PROFYLE)

    For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE, a pan-Canadian project to give children, adolesce...

    Read More
  • Pancreatic Cancer

    Investigating radiation response of pancreatic tumours, their vasculature and microenvironment using in vivo imaging to identify new treatment strategies

    While survival rates for many cancers have improved over the last decade, cure rates for some forms of the disease – such as pancreatic cancer – remain as low as just two to three per cent...

    Read More
  • Multiple Cancers

    Next generation cancer immunovirotherapy: heterologous oncolytic prime-boost enhanced with selected immunomodulators

    What if there was a way to destroy cancer cells and stimulate a patient’s own immune system to attack tumours, while leaving healthy tissues unharmed?   The Terry Fox Research Institute (TF...

    Read More
  • All Cancers

    Clinician-scientists in molecular oncologic pathology

    Over the last decade there has been exponential growth in our understanding of the molecular basis of cancer. This is being driven by technical advances across a broad range of disciplines, including ...

    Read More
  • Multiple Cancers

    Oncometabolism and the molecular pathways that fuel cancer

    Cancer cells flourish in our bodies by overcoming significant internal and external stresses and constantly adapting to new environments. Armed with new funding from the Terry Fox Research Institute a...

    Read More
  • Multiple Cancers

    Development of stemness-based prognostic biomarkers and therapeutic targets

    There is an analogy senior scientist Dr. John Dick uses when explaining his TFRI-funded cancer stem cell (CSC) research. He compares cancer to a weed that has a separate root to the stem, branches and...

    Read More
  • All Cancers

    Discovery and therapeutic development of antibody-based targets in oncology

    Many chemotherapeutic drugs used to treat cancer result in tremendous toxicities for patients that can have many negative side effects - including some that are long-lasting - without ever actually cu...

    Read More
  • Sarcoma

    Development of cutting-edge biotherapies for the treatment of bone cancers

    Viral immunologist Dr. Byram Bridle has developed an innovative new way to treat osteosarcoma, the same type of bone cancer that took Terry Fox’s life – and next year will start canine cli...

    Read More
  • Multiple Cancers

    Research pipeline for hypoxia-directed precision cancer medicine

    A new approach for a long-time funded Terry Fox research program has leaders of the initiative excited about personalizing treatment for cancer patients by bringing together two areas of study: genomi...

    Read More
  • Multiple Cancers

    Killing the hydra: genetic dissection of actionable targets required for maintenance of metastatic disease

    Even senior scientists can be surprised by new data - something Dr. Sean Egan experienced when he found out that breast cancer metastasis can be very different from their original primary tumour. Dr...

    Read More